We are live on ! Find out more
ABBV icon

AbbVie
ABBV

1,286 hedge funds and large institutions have $44.6B invested in AbbVie in 2013 Q2 according to their latest regulatory filings, with 1,286 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68.14% more ownership

Funds ownership: 0% → 68.14% (+68%)

33% more call options, than puts

Call options by funds: $182M | Put options by funds: $137M

Holders
1,286
Holders Change
+1,286
Holders Change %
–
% of All Funds
41.97%
Holding in Top 10
39
Holding in Top 10 Change
+39
Holding in Top 10 Change %
% of All Funds
1.27%
New
1,286
Increased
–
Reduced
–
Closed
–
Calls
$182M
Puts
$137M
Net Calls
+$45.2M
Net Calls Change
+$45.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Legal & General Group
26
Legal & General Group
United Kingdom
$291M +$308M +7,046,417 New
Goldman Sachs
27
Goldman Sachs
New York
$289M +$306M +6,996,102 New
EIP
28
Epoch Investment Partners
New York
$284M +$301M +6,872,496 New
CI Investments Inc
29
CI Investments Inc
Ontario, Canada
$269M +$284M +6,500,000 New
Franklin Resources
30
Franklin Resources
California
$267M +$283M +6,464,113 New
American Century Companies
31
American Century Companies
Missouri
$253M +$268M +6,119,884 New
Morgan Stanley
32
Morgan Stanley
New York
$252M +$267M +6,097,943 New
BlackRock
33
BlackRock
New York
$250M +$264M +6,039,657 New
Primecap Management
34
Primecap Management
California
$247M +$262M +5,979,247 New
PAM
35
Panagora Asset Management
Massachusetts
$234M +$248M +5,659,775 New
PC
36
PointState Capital
New York
$232M +$246M +5,620,400 New
Fayez Sarofim & Co
37
Fayez Sarofim & Co
Texas
$231M +$244M +5,579,640 New
Massachusetts Financial Services
38
Massachusetts Financial Services
Massachusetts
$229M +$242M +5,535,777 New
Capital International Investors
39
Capital International Investors
California
$224M +$237M +5,417,000 New
Deutsche Bank
40
Deutsche Bank
Germany
$220M +$233M +5,318,940 New
BIM
41
BlackRock Investment Management
Delaware
$220M +$233M +5,317,144 New
Neuberger Berman Group
42
Neuberger Berman Group
New York
$213M +$225M +5,141,914 New
LSV Asset Management
43
LSV Asset Management
Illinois
$207M +$219M +4,998,815 New
PNC Financial Services Group
44
PNC Financial Services Group
Pennsylvania
$205M +$217M +4,964,076 New
Arrowstreet Capital
45
Arrowstreet Capital
Massachusetts
$200M +$211M +4,826,765 New
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$199M +$210M +4,808,962 New
Schroder Investment Management Group
47
Schroder Investment Management Group
United Kingdom
$194M +$206M +4,702,424 New
APG Asset Management
48
APG Asset Management
Netherlands
$189M +$200M +4,562,235 New
Principal Financial Group
49
Principal Financial Group
Iowa
$185M +$196M +4,480,503 New
Prudential Financial
50
Prudential Financial
New Jersey
$177M +$187M +4,277,955 New
1
2
3 4 5

ABBV Hedge Fund Activity: Q2 2013 in Review

1,286 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q2 2013, worth a combined $44.6B.

Buyers outnumbered sellers: 1,286 funds opened new ABBV positions and 0 closed out — a net gain of 1,286 holders — while 0 added to existing stakes and 0 trimmed.

  • 1,286 institutional investors held AbbVie (ABBV) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $44.6B of AbbVie stock for Q2 2013.
  • 1,286 funds opened new AbbVie positions in Q2 2013 and 0 closed out, a net change of +1,286 holders.

Based on aggregated 13F filings for Q2 2013.